Key Takeaways
- Shares of RKLB have declined 8% since January, currently trading at $64.26—significantly below the 12-month peak of $151.00
- Analyst consensus remains at Strong Buy, with an average target of $108.88 suggesting 69% potential appreciation
- Cantor Fitzgerald upgraded its target to $122, highlighting strong Q2 performance and Neutron’s progress
- Bank of America adjusted its target down to $110 from $115 while maintaining a Buy stance, referencing the $2.36 billion order book
- The Saudi Central Bank increased its RKLB holdings by over 100% in Q2; ARK Invest recently acquired more than 705,000 shares
Shares of Rocket Lab (RKLB) began Monday’s session at $64.26, marking an approximately 8% retreat from the year’s opening level. The aerospace company has experienced a sharp 49% decline across the last three months, trading well beneath its 12-month zenith of $151.00.
Nonetheless, the Street’s conviction remains firm. RKLB commands a Strong Buy consensus rating, backed by 13 Buy recommendations and four Hold positions. Analysts’ mean price objective of $108.88 indicates approximately 69% upside from current levels.
Cantor Fitzgerald’s Andres Sheppard elevated his target to $122 from $96 while reaffirming his Buy recommendation. His bullish stance reflects confidence in the company’s second-quarter performance and management’s assurance that the Neutron launch vehicle stays on course for its inaugural flight this year.
Sheppard characterized Rocket Lab’s proposed Iridium acquisition as “transformational,” projecting the merged entity will achieve double its current annual revenue following deal completion.
Neutron Launch Vehicle Drives Future Growth
The Neutron program represents the cornerstone of Rocket Lab’s expansion strategy. This reusable medium-lift vehicle is designed to capture significantly more market share than the company’s existing Electron platform.
Yet uncertainty looms. Industry sources indicate Neutron’s maiden launch might be postponed until 2027, potentially delaying substantial revenue streams. Bank of America’s Ronald Epstein identified the development schedule as “a key aspect to watch,” acknowledging that while a Q4 2026 demonstration flight remains feasible, the timeline is increasingly compressed.
Epstein reduced his price objective to $110 from $115, adjusting for increased share dilution, while preserving his Buy recommendation. His confidence stems from Rocket Lab’s “strong positioning across launch and space systems capabilities” and the company’s robust $2.36 billion contracted backlog encompassing over 90 scheduled launches.
Major Institutions Increase Positions
On the institutional front, the Saudi Central Bank expanded its RKLB holdings dramatically during Q2, purchasing 18,670 additional shares to reach a total position of 36,415 shares worth approximately $3.7 million. Meanwhile, ARK Invest accumulated over 705,000 shares through two recent trading sessions.
Institutional investors and hedge funds currently control 71.78% of outstanding RKLB shares.
This accumulation stands in contrast to insider transactions. CFO Adam Spice divested 140,157 shares on September 2nd at $62.63 per share, generating proceeds of approximately $8.78 million through a predetermined Rule 10b5-1 trading arrangement.
During the second quarter, Rocket Lab delivered revenue of $234.07 million, surpassing Wall Street’s $231.62 million projection. However, earnings per share of -$0.08 fell short of the -$0.06 consensus. The company continues to operate at a loss, with full-year EPS estimates at -$0.20.
An encouraging development emerged last week when Planet Labs highlighted increasing capacity constraints within SpaceX’s rideshare program, potentially redirecting customers to alternative providers including Rocket Lab.
The aerospace firm also achieved its 94th consecutive successful launch and maintains a mission manifest with 16 confirmed flights extending through 2030.


